Jasna Mihailović
Full Professor
Oncology Institute of Vojvodina, Center for Nuclear Medicine
jasna.mihailovic@mf.uns.ac.rs
Phone: 0214805100
ORCID ID : 0000-0002-6400-4495
Oncology Institute of Vojvodina, Center for Nuclear Medicine
jasna.mihailovic@mf.uns.ac.rs
Phone: 0214805100
ORCID ID : 0000-0002-6400-4495
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2017 |
Faculty of Medicine Novi Sad |
Radiology | PhD |
1999 |
Faculty of Medicine Novi Sad |
Nuclear medicine |
Specialization |
1993 |
Faculty of Medicine Novi Sad |
Nuclear medicine |
MSc |
1991 |
Faculty of Medicine Novi Sad |
Nuclear medicine |
Graduated |
1985 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
21 | Mihailovic J, Stefanovic Lj, Stankovic R. Influence of initial treatment on the survival and recurrence in patients with differentiated thyroid microcarcinoma. Clin Nucl Med 2013;38(5):332-338. |
21a | Mihailovic J, Nikoletic K, Srbovan D. Recurrent Disease in Juvenile Differentiated Thyroid Carcinoma: Prognostic Factors, Treatment and Outcome. J Nucl Med 2014;55:701-717. |
21 | Mihailovic J, Goldsmith SJ. Multiple Myeloma: F-18-FDG-PET/CT and Diagnostic Imaging. Sem Nucl Med 2015; 45(1):16-31. |
21a | Giorgio T, Cumali A, Arturo C, Savvas F, Luca G, Martha H, Ioannis I, Mihailovic J, Bernd KJ, Werner L, Verburg FA, Luster M. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine. EJNMMI 2016; 43(8):1486-1490. |
21a | Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M. Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2016;43(6):1001-1005. |
21a | Verburg Frederik A, Giovanella Luca, Iakovou Ioannis, Konijnenberg Mark W, Langsteger Werner, Lassmann Michael, Mihailovic Jasna M, Luster Markus. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth? Eur J Nucl Med Mol Imaging 2018;45(13):2247-2249. |
21 | Mihailovic J, Killeen RP, Duignan JA. PET/CT variants and pitfalls in head and neck cancers including thyroid cancer. Sem Nucl med 2021;51(5):419-440. |
21 | Reiners C, Schneider R, Platonova T, Fridman M, Malzahn U, Mäder U, Vrachimis A, Bogdanova T, Krajewska J, Elisei R, Vaisman F, Mihailovic J, Costa G, Drozd V. Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey. Frontiers in Endocrinology 2020;11:381. doi: 10.3389/fendo.2020.00381 |
21a | Petranović Ovčariček, P., Verburg, F.A., Hoffmann, Iakovou I, Mihailovic J, Vrachimis A, Luster M, Giovanella L. Higher thyroid hormone levels and cancer. Eur J Nucl Med Mol Imaging 2021;48:808-821. |
21 | Stankovic A , Mihailovic J, Mirkovic M, Radovic M, Milanovic Z, Ognjanovic M, Jankovic D, Antic B, Mijovic M, Vranjes-Djuric S, Prijovic Z. Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to131I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer. International Journal of Pharmaceutics 587 (2020) 119628 |
| Course | Studies |
|---|---|
Radiology equipment and quality control | Undergraduate applied studies in radiologic technology |
Clinical radiology | Integrated Academic Studies in Medicine |
Mathematical models in clinical reasearch | Doctoral acdemic studies |
Elective – Nuclear medicine | Integrated Academic Studies in Medicine |